COHERUS ONCOLOGY, INC.

Coherus Biosciences, Inc. specializes in the manufacturing of high-complexity pharmaceutical preparations, with a focused expertise in biosimilar and specialty injectable products, particularly pegfilgrastim in syringe and autoinjector formulations. The company delivers end-to-end pharmaceutical manufacturing services, including sterile solution preparation, vial filling, and supply chain logistics under strict cGMP standards. Their technical proficiency spans biologics formulation, cold chain management, and validated production processes for hematologic and oncology therapeutics, with demonstrated experience in vendor-managed inventory (VMI) models that ensure uninterrupted federal supply chains. Coherus distinguishes itself through consistent compliance with FDA regulatory frameworks and the ability to scale production for large-scale government procurement programs requiring high reliability and batch traceability. The contractor maintains a strong, recurring relationship with the Department of Veterans Affairs and the Department of Health and Human Services, primarily supplying critical oncology and hematologic pharmaceuticals through Federal Supply Schedule contracts and direct procurement vehicles. Their work supports VA’s mission to deliver consistent, high-quality medication access to veterans and HHS initiatives focused on securing affordable biologic alternatives for public health programs. Coherus operates exclusively within NAICS 325412 — Pharmaceutical Preparation Manufacturing — positioning itself as a niche provider of biosimilar injectables within the federal healthcare market. Their vertical specialization lies in complex, high-demand biologics used in cancer care and supportive therapy, serving as a trusted source for government agencies requiring FDA-approved, cost-effective alternatives to originator products. As a privately held entity headquartered in Redwood City, California, Coherus Biosciences, Inc. is structured as a 2L entity with no federal certifications on record. The company maintains a focused geographic footprint centered on its California manufacturing and operational base, serving as a key supplier to U.S. government health systems through specialized pharmaceutical production capabilities.